谷歌浏览器插件
订阅小程序
在清言上使用

Evaluating Metrics of Circulating Tumor DNA Response and Progression Using a High Sensitivity Tumor-Agnostic Assay in Metastatic HR+/HER2- Breast Cancer Receiving Endocrine Therapy and a CDK4/6-inhibitor.

Journal of Clinical Oncology(2024)

引用 0|浏览21
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要